Huijberts M - Search Results

1

Anisotropic reentry in a perfused 2-dimensional layer of rabbit ventricular myocardium.

Schalij MJ, Boersma L, Huijberts M, Allessie MA. Schalij MJ, et al. Among authors: huijberts m. Circulation. 2000 Nov 21;102(21):2650-8. doi: 10.1161/01.cir.102.21.2650. Circulation. 2000. PMID: 11085970

2

Effects of bepridil on conduction properties of the isolated rabbit sinus node and atrial myocardium.

Kirchhof CJ, Bonke FI, Allessie MA, Huijberts MS. Kirchhof CJ, et al. Among authors: huijberts ms. J Cardiovasc Pharmacol. 1989 Jan;13(1):131-7. J Cardiovasc Pharmacol. 1989. PMID: 2468924

3

Inhibition of angiotensin-converting enzyme reduces urinary albumin excretion but not regional albumin clearance in experimental diabetes.

Huijberts M, Wolffenbuttel B, Crijns F, Kruseman AN, Bemelmans M, Van Essen H, Smits J, Boudier HS. Huijberts M, et al. Eur J Pharmacol. 1993 Aug 24;240(2-3):207-12. doi: 10.1016/0014-2999(93)90900-3. Eur J Pharmacol. 1993. PMID: 8243539

4

Breakers of advanced glycation end products restore large artery properties in experimental diabetes.

Wolffenbuttel BH, Boulanger CM, Crijns FR, Huijberts MS, Poitevin P, Swennen GN, Vasan S, Egan JJ, Ulrich P, Cerami A, Lévy BI. Wolffenbuttel BH, et al. Among authors: huijberts ms. Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4630-4. doi: 10.1073/pnas.95.8.4630. Proc Natl Acad Sci U S A. 1998. PMID: 9539789 Free PMC article.

5

Aminoguanidine reduces regional albumin clearance but not urinary albumin excretion in streptozotocin-diabetic rats.

Huijberts MS, Wolffenbuttel BH, Crijns FR, Nieuwenhuijzen Kruseman AC, Bemelmans MH, Struijker Boudier HA. Huijberts MS, et al. Diabetologia. 1994 Jan;37(1):10-4. doi: 10.1007/BF00428771. Diabetologia. 1994. PMID: 8150221

6

Miglitol, a new alpha-glucosidase inhibitor.

Sels JP, Huijberts MS, Wolffenbuttel BH. Sels JP, et al. Among authors: huijberts ms. Expert Opin Pharmacother. 1999 Nov;1(1):149-56. doi: 10.1517/14656566.1.1.149. Expert Opin Pharmacother. 1999. PMID: 11249557 Review.

7

Rosiglitazone.

Wolffenbuttel BH, Sels JP, Huijberts MS. Wolffenbuttel BH, et al. Among authors: huijberts ms. Expert Opin Pharmacother. 2001 Mar;2(3):467-78. doi: 10.1517/14656566.2.3.467. Expert Opin Pharmacother. 2001. PMID: 11336599 Review.

8

Aminoguanidine, a potential drug for the treatment of diabetic complications.

Wolffenbuttel BH, Huijberts MS. Wolffenbuttel BH, et al. Among authors: huijberts ms. Neth J Med. 1993 Jun;42(5-6):205-8. Neth J Med. 1993. PMID: 8377878 No abstract available.

9

Hip bone mineral density, bone turnover and risk of fracture in patients on long-term suppressive L-thyroxine therapy for differentiated thyroid carcinoma.

Heijckmann AC, Huijberts MS, Geusens P, de Vries J, Menheere PP, Wolffenbuttel BH. Heijckmann AC, et al. Eur J Endocrinol. 2005 Jul;153(1):23-9. doi: 10.1530/eje.1.01933. Eur J Endocrinol. 2005. PMID: 15994742

10

[Adequate adjustment of diabetes mellitus decreases the possibility of diabetic complications].

Wolffenbuttel BH, Huijberts MS, Heesen BJ, Leurs PB, Nieuwenhuijzen Kruseman AC. Wolffenbuttel BH, et al. Among authors: huijberts ms. Ned Tijdschr Geneeskd. 1993 Oct 23;137(43):2179-83. Ned Tijdschr Geneeskd. 1993. PMID: 8247161 Dutch. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters